Besides great expectations in terms of public health and nature protection gene drives (GD) have raised serious concerns because of their inherent functionality to spread and invade natural populations. Not only does this novel technology pose a paradigm shift for the release of genetically engineered organisms (GMOs) as GDs are intended to spread within wild populations. A released GD thus represents an unprecedented intervention into the molecular foundation of natural populations, transforming them into GMOs themselves. Once released, it can hardly be retrieved at the current stage of development. The investigations of the potential impacts of GD-applications are complex and still at the very beginning. Up to now, consequences are not foreseeable in the case of malfunction. Thus, precautionary risk management has to find ways to adequately deal with lacking knowledge up to complete ignorance about potential adverse effects. Three main options are available for risk management, first, a reduction of exposure by strategies of containment, second, a substitution by socio-technical alternatives that fulfil comparable functions combined with lower exposure- and hazard potentials and third an integration of responsible research and innovation in the technological development by choosing potential low risk development paths from the very beginning. In this chapter, we analyse and compare different types of gene drives as well as promising alternative approaches that may provide a reduced risk potential.
1 May 2023 in GAIA - Ecological Perspectives for Science and Society
Engineered gene drives are an emerging technology for the large-scale genetic modification of natural populations of species. They are controversial due to high levels of uncertainty about their risks and benefits. We analyze gene drives in their social, natural, and technological contexts. We discuss their depth of intervention and compare gene drives to “conventional” genetic modification techniques and to other novel high-impact technologies. While gene drives might overpromise and under-deliver solutions for problems of sustainable development, they also represent a paradigm shift in human technological interference with nature, thus requiring broad discussion in society.
If genetically modified organisms (GMOs) are approved in the EU for experimental release or marketing authorization (placing on the market), a risk assessment (RA) is carried out beforehand to determine whether this may be associated with negative effects on human health, nature or the environment. Applications are reviewed by the European Food Safety Authority (EFSA) and the national Competent Authorities of the Member States. However, the potential ramifications of the GMOs that are systematically addressed in the current RA context are limited. Broader consideration can include environmental and health aspects beyond the scope of the statutory RA, as well as societal, ethical and cultural impacts. These other levels of impact may be considered during the comitology process of authorisation, but how this is done is typically not made explicit in a systematic way. However, with the dynamic developments of new kinds of GMOs, these considerations as well as transparency regarding the role of broader considerations in political decision-making become more and more relevant. Against this backdrop, we identified the requirements and suggest the main elements for such a broader assessment. We use insights from the field of Technology Assessment (TA) to explore the requirements for operationalising a rapid but still systematic, transparent and broad case-by-case GMO assessment compatible with the existing legislative framework.